» Articles » PMID: 21383498

IL-2 Induces a WAVE2-dependent Pathway for Actin Reorganization That Enables WASp-independent Human NK Cell Function

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2011 Mar 9
PMID 21383498
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Wiskott-Aldrich syndrome (WAS) is a primary immunodeficiency associated with an increased susceptibility to herpesvirus infection and hematologic malignancy as well as a deficiency of NK cell function. It is caused by defective WAS protein (WASp). WASp facilitates filamentous actin (F-actin) branching and is required for F-actin accumulation at the NK cell immunological synapse and NK cell cytotoxicity ex vivo. Importantly, the function of WASp-deficient NK cells can be restored in vitro after exposure to IL-2, but the mechanisms underlying this remain unknown. Using a WASp inhibitor as well as cells from patients with WAS, we have defined a direct effect of IL-2 signaling upon F-actin that is independent of WASp function. We found that IL-2 treatment of a patient with WAS enhanced the cytotoxicity of their NK cells and the F-actin content at the immunological synapses formed by their NK cells. IL-2 stimulation of NK cells in vitro activated the WASp homolog WAVE2, which was required for inducing WASp-independent NK cell function, but not for baseline activity. Thus, WAVE2 and WASp define parallel pathways to F-actin reorganization and function in human NK cells; although WAVE2 was not required for NK cell innate function, it was accessible through adaptive immunity via IL-2. These results demonstrate how overlapping cytoskeletal activities can utilize immunologically distinct pathways to achieve synonymous immune function.

Citing Articles

Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing.

Perucca A, Llonin A, Benach O, Hallopeau C, Rivas E, Linares J Nat Commun. 2025; 16(1):1279.

PMID: 39900918 PMC: 11790944. DOI: 10.1038/s41467-025-56275-1.


Interleukin signaling in the regulation of natural killer cells biology in breast cancer.

Xu J, Gao H, Azhar M, Xu H, Chen S, Li M Front Immunol. 2024; 15:1449441.

PMID: 39380989 PMC: 11459090. DOI: 10.3389/fimmu.2024.1449441.


β-Actin G342D as a Cause of NK Cell Deficiency Impairing Lytic Synapse Termination.

Reed A, Peraza J, van den Haak F, Hernandez E, Gibbs R, Chinn I J Immunol. 2024; 212(6):962-973.

PMID: 38315012 PMC: 11337350. DOI: 10.4049/jimmunol.2300671.


NgR1 is an NK cell inhibitory receptor that destabilizes the immunological synapse.

Oh S, Kim S, Jang I, Kim S, Lee S, Lee S Nat Immunol. 2023; 24(3):463-473.

PMID: 36624164 DOI: 10.1038/s41590-022-01394-w.


Partial loss-of-function mutations in GINS4 lead to NK cell deficiency with neutropenia.

Conte M, Poli M, Taglialatela A, Leuzzi G, Chinn I, Salinas S JCI Insight. 2022; 7(21).

PMID: 36345943 PMC: 9675456. DOI: 10.1172/jci.insight.154948.


References
1.
Sullivan K, Mullen C, Blaese R, Winkelstein J . A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994; 125(6 Pt 1):876-85. DOI: 10.1016/s0022-3476(05)82002-5. View

2.
Carrizosa E, Gomez T, Labno C, Klos Dehring D, Liu X, Freedman B . Hematopoietic lineage cell-specific protein 1 is recruited to the immunological synapse by IL-2-inducible T cell kinase and regulates phospholipase Cgamma1 Microcluster dynamics during T cell spreading. J Immunol. 2009; 183(11):7352-61. PMC: 3715746. DOI: 10.4049/jimmunol.0900973. View

3.
Banerjee P, Orange J . Quantitative measurement of F-actin accumulation at the NK cell immunological synapse. J Immunol Methods. 2010; 355(1-2):1-13. PMC: 2854315. DOI: 10.1016/j.jim.2010.02.003. View

4.
Orange J, Ramesh N, Remold-ODonnell E, Sasahara Y, Koopman L, Byrne M . Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci U S A. 2002; 99(17):11351-6. PMC: 123260. DOI: 10.1073/pnas.162376099. View

5.
Schnee A, Jenkins M, Thall P, Aggarwal B, Talpaz M, Estrov Z . Serum cytokine levels in infectious mononucleosis at diagnosis and convalescence. Leuk Lymphoma. 1998; 30(5-6):583-9. DOI: 10.3109/10428199809057570. View